The J-curve in arterial hypertension: fact or fallacy?

Evangelia P Tsika1, Leonidas E Poulimenos, Konstantinos Dean Boudoulas

  • 1Cardiology Department, Asklepeion Hospital, Athens, Greece.

Cardiology
|September 18, 2014
PubMed

Insights

Many patients with high blood pressure are undertreated, increasing cardiovascular risks. However, overly aggressive blood pressure reduction can also be harmful, especially in those with coronary artery disease or left ventricular hypertrophy.

Area of Science:

  • Cardiology
  • Hypertension Management

Background:

  • A significant number of patients with arterial hypertension remain undertreated, contributing to increased cardiovascular event rates.
  • Conversely, overly aggressive blood pressure reduction can paradoxically elevate cardiovascular events, a phenomenon known as the J-curve.

Purpose of the Study:

  • To review the J-curve phenomenon in hypertension management.
  • To identify patient populations at risk for adverse outcomes with aggressive blood pressure lowering.
  • To discuss updated guideline recommendations for safer blood pressure targets.

Main Methods:

  • Literature review of studies on blood pressure management and cardiovascular outcomes.
  • Analysis of the J-curve phenomenon in specific patient subgroups.
  • Examination of current European hypertension guidelines.

Main Results:

  • The J-curve phenomenon, where excessively low blood pressure increases cardiovascular events, is observed in patients with coronary artery disease and left ventricular hypertrophy when diastolic blood pressure falls below 70-80 mm Hg or systolic below 130 mm Hg.
  • This phenomenon is not typically seen in patients with stroke or renal disease.
  • Recent guidelines suggest higher blood pressure targets for specific patient groups, including the elderly and those with certain cardiovascular conditions.

Conclusions:

  • A conservative blood pressure management strategy is crucial for patients with coronary artery disease, left ventricular hypertrophy, the elderly, and isolated systolic hypertension.
  • Adherence to updated European Society of Hypertension/European Society of Cardiology guidelines is recommended for optimizing patient outcomes.
  • Individualized blood pressure targets are essential to balance the risks of undertreatment and overtreatment.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.6K
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
7.5K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
913
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
23